SEMA3D and hepatocellular carcinoma: Furthermore, to confirm Pi3k/Akt signaling inactivated by Sema3d in HCC, the Sema3d-interfered HCC cells were treated with or without Wortmannin for 48 h, which was verified as a functional inhibitor of Pi3k/Akt signaling (29, 30).